Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability.

Bing Hu,Yuwen Ting,Xiaoqing Yang,Wenping Tang,Xiaoxiong Zeng,Qingrong Huang
DOI: https://doi.org/10.1039/c2cc17295j
IF: 4.9
2012-01-01
Chemical Communications
Abstract:Nanochemoprevention by oral consumption was developed by the encapsulation of (-)-epigallocatechin-3-gallate (EGCG) with nanoparticles that were electrostatically assembled from bioactive caseinophosphopeptides and chitosan, which was highly biocompatible and able to enhance the bioavailability of EGCG.
What problem does this paper attempt to address?